The post Pfizer – World Class Benchmarking appeared first on Become a Better Investor.
Company: Pfizer Incorporated
Bloomberg ticker: PFE US
Market cap: US$153,536m
Background: Pfizer Incorporated is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide.
World Class Benchmarking of Pfizer
- Profitable Growth rank of 5 was down compared to the prior period’s 1st rank
- This is average performance compared to 380 large Health Care companies worldwide
- Profitability rank of 4 was better than its Growth rank of 9
- Profitability rank of 4 was down compared to the prior period’s 1st rank
- This is above average performance compared to peers
- Growth rank of 9 was down compared to the prior period’s 3rd rank
- This is poor performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.
Read more articles like this on Become a Better Investor.
